Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Insulin Polyphagia, Liver Fat, and Choline

Burhz Hoklley

Insulin polyphagia, liver fat accumulation, and choline have gained considerable attention in the field of metabolic research. Insulin polyphagia refers to excessive hunger and increased food consumption resulting from insulin resistance. Non-alcoholic fatty liver disease (NAFLD) is characterized by abnormal fat accumulation in the liver, often associated with insulin resistance. Choline, an essential nutrient, has emerged as a potential modulator of these metabolic processes. This abstract provides a concise overview of the interplay between insulin polyphagia, liver fat, and choline. Insulin polyphagia arises from disrupted insulin signaling and is commonly observed in conditions such as obesity and type 2 diabetes. Hyperinsulinemia, a hallmark of insulin resistance, disturbs the normal feedback loop between insulin and appetite regulation centers in the brain, leading to increased hunger and overeating. NAFLD, closely linked to insulin resistance, encompasses a range of liver conditions characterized by excess fat accumulation. Elevated insulin levels promote fat synthesis and hinder fat oxidation in the liver, resulting in hepatic steatosis. Insulin resistance further exacerbates metabolic disturbances by impairing the suppression of hepatic glucose production.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.